Monocyte Ratios, APRs, and Sepsis ICU Study
Summary
NIH's ClinicalTrials.gov registered a new observational study (NCT07537179) examining whether monocyte distribution, monocyte-to-lymphocyte ratio, and neutrophil-to-lymphocyte ratio can serve as biomarkers in sepsis patients in the ICU. The study will enroll patients admitted to the ICU for sepsis or those who develop sepsis during hospitalization, comparing these ratios with conventional acute phase response biomarkers.
What changed
ClinicalTrials.gov published registration for NCT07537179, a new observational study examining monocyte distribution width (MDW), monocyte-to-lymphocyte ratio (MLR), and neutrophil-to-lymphocyte ratio (NLR) as potential biomarkers in sepsis patients in the ICU setting. The study will enroll patients admitted to the ICU who either present with sepsis as a primary diagnosis or develop sepsis secondarily.
For clinical investigators and research institutions, this represents an addition to the body of clinical research on sepsis diagnostics. The study may inform future discussions on biomarker utilization in critical care settings but does not create any compliance obligations. Healthcare providers interested in sepsis research may monitor this study for potential implications on clinical practice guidelines.
Archived snapshot
Apr 18, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Investigation of the Relationship Between MD, MLR and NLR With APRs in Sepsis in the ICU
Observational NCT07537179 Kind: OBSERVATIONAL Apr 17, 2026
Abstract
The aim of this study is to investigate, in patients admitted to the intensive care unit either for reasons other than sepsis who subsequently develop sepsis or with a primary diagnosis of sepsis, whether monocyte distribution, monocyte-to-lymphocyte ratio, and neutrophil-to-lymphocyte ratio can be used in addition to conventional biomarkers, and to examine their relationships with these biomarkers.
Conditions: Sepsis, Intensive Care (ICU), Acute Phase Biomarkers
Interventions: Monocyte Distribution
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.